AzTrials
AzTrials

Varicose Vein DiseaseNCT01103258

FOAM-study, Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins

A study testing high ligation and stripping (surgery) and FOAM in people with Varicose Vein Disease, run by Maastricht University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Varicose vein disease is a common health problem, which causes much discomfort to patients. Nowadays treatment modalities for greater saphenous veins include surgery and duplex guided foam sclerotherapy. These are two equally accepted and applied treatments for the same patient population. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Varicose Vein Disease
What is being tested?
high ligation and stripping (surgery) and FOAM
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
460 participants
Where
1 siteNetherlands
Study dates
Feb 2006to Jan 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • incompetence of great saphenous vein for minimal 20 cm
  • life expectancy at least 3 years
  • open and competent deep venous system
  • willing to undergo both treatments

Who cannot join

  • active ulcer
  • signs of deep venous thrombosis with duplex
  • incompetence of the deep venous system

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht UMC

    Maastricht

Other trials in Netherlands

About this study

Official title: FOAM-study Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins: a Randomized Controlled Study

Varicose vein disease is a common health problem, which causes much discomfort to patients.

Nowadays treatment modalities for greater saphenous veins include surgery and duplex guided foam sclerotherapy. These are two equally accepted and applied treatments for the same patient population.

Choice of treatment often depends on the referral preference of the General Practitioner. Until now data are missing which treatment is more cost effective. The current proposal aims at comparing the effects, costs and patient preferences between duplex guided foam sclerotherapy and surgery in the treatment of greater varicose veins.

Being tested
high ligation and stripping (surgery), FOAM
Keywords
Incompetence of the great saphenous vein.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • high ligation and stripping (surgery)Procedure or surgery

    surgery consisting of high ligation in combination with long saphenous stripping

  • FOAMProcedure or surgery

    duplex guided foam sclerotherapy

Study groups in NCT01103258
Study groupRoleWhat they receive
high ligation and strippingActive comparatorsurgery consisting of high ligation in combination with long saphenous stripping
Receives: Procedure: high ligation and stripping (surgery)
duplex guided foam sclerotherapyActive comparatorduplex guided foam sclerotherapy
Receives: Procedure: FOAM

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cumulative probability of recurrent varicose vein within 24 months after treatment

    Measured: 24 months

Secondary outcomes (3)
  1. quality of life (as measured by EuroQol-5D)

    Measured: 24 months

  2. patient preferences (as measured by conjoint analysis)

    Measured: 24 months

  3. direct Health care costs

    materials, operation costs, personnel costs

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2010 (estimated)
  2. Study startFeb 2006
  3. Primary completionDec 2009
  4. Study completionJan 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
460 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01103258
Sponsor's protocol ID
MEC 05-2-014
Other IDs
ZON MW 4636
Status last verified
Apr 2010
First submitted
6 Apr 2010
Last updated
14 Apr 2010
Results posted
No
Data monitoring committee
No

Publications

  • Shadid N, Ceulen R, Nelemans P, Dirksen C, Veraart J, Schurink GW, van Neer P, vd Kley J, de Haan E, Sommer A. Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein. Br J Surg. 2012 Aug;99(8):1062-70. doi: 10.1002/bjs.8781. Epub 2012 May 25.

    PubMed 22627969

Questions about this trial

What is this clinical trial studying?

A study testing high ligation and stripping (surgery) and FOAM in people with Varicose Vein Disease, run by Maastricht University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cumulative probability of recurrent varicose vein within 24 months after treatment (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01103258, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in